跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,620 条关于
“BioCryst Pharma”
全部
9,620
临床试验
4,082
药物
1,118
机构
1,223
资讯
3,197
5个月前
BioCryst Pharmaceuticals Appoints Sandeep M. Menon as Chief Research and Development Officer
去年
BioCryst Pharmaceuticals Appoints Babar Ghias as CFO and Head of Corporate Development
去年
BioCryst Pharmaceuticals Divests European ORLADEYO Rights for $264 Million to Achieve Debt-Free Status
2年前
Clearside Biomedical's CLS-AX Phase IIb Trial Readout Anticipated in Q3 2024
去年
Hereditary Angioedema Pipeline Shows Robust Growth with 30+ Therapies in Development Across Multiple Clinical Stages
去年
BioCryst Names Charlie Gayer as New CEO Following Jon Stonehouse's Retirement Announcement
去年
BioCryst's Orladeyo® (berotralstat) Receives Recommendation in Ireland for HAE Prophylaxis
去年
IgA Nephropathy Pipeline Shows Robust Growth with 30+ Therapies in Development
去年
BioCryst's Orladeyo Demonstrates Safety and Efficacy in Pediatric Hereditary Angioedema Trial
11个月前
BioCryst Acquires Astria Therapeutics for $700 Million to Expand Hereditary Angioedema Treatment Portfolio
第 1 页,共 320 页
上一页
下一页